The effects of genistein, a tyrosine kinase inhibitor on acute and chronic inflammation in diabetic mice

Daru

Volumn 14, Issue 1, 2006, Pages 6-10

  Fatehi, Mohammad ^a   Jafarzadeh, Mostafa ^a   Fatehi Hassanabad, Zahra ^a   Gholamnezhad, Zahra ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Genistein; Inflammation; Mice; Streptozotocin; Tyrosine kinase

Indexed keywords

CARRAGEENAN; GENISTEIN; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; PROTEIN TYROSINE KINASE INHIBITOR; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; COTTON; DRUG EFFECT; INFLAMMATION; MALE; MOUSE; NONHUMAN; PAW EDEMA; STREPTOZOCIN DIABETES;

EID: 33745663749     PISSN: 15608115     EISSN: 15608115     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Akarasereenont P, Mitcchell La, Bakhle YS, Thiemermann C, Vane JR, Comparison of the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages. Eur J Pharmacol 1995; 273: 121-8.
2. Sautebin L, Ialenti A, Di Rosa M. Relationship between nitric oxide and prostaglandins in carrageenin pleurisy. Biochem Pharmacol 1998; 55: 1113-7.
3. Cuzzocrea S., Zingarelli, B., Gilard E, Hake P. Salzman AL, Szabo C. Anti-inflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Rad Biol Med. 1998; 24: 450-9.
4. Ciampolillo A, Guastamacchia E, Caragiulo L, Lollino G, De Robertis O, Latanzi V, Giorgino R, In vivo secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients. Diabetes Res Clin Pract 1993; 21: 87-93.
5. Hussain MJ, PeakmanM, Gallati H, Lo SS, HawaM, Viberti GC, Wakins PJ, Leslie RD, Vergani D, Eleveted serum levels of macrophafe-dervied cytokines precede and accompany the onset of IDDM. Diabetologia 1996; 39: 60-69.
6. Dinarello CA, Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652.
7. Kushner I, Regulation of acute phase response by cytokines. Perspect Biol Med 1993; 36: 611-622.
8. Omi H, Okayama N, Shimizu M, Okouachi M, Ito S, Fukutomi T. Participation of high glucose concentration in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells Effect of antidiabetic medicines. J diabetes complication 2002; 16: 201-208.
9. Fatehi M, Anvari, K, Fatehi-hassanabad Z, The beneficial effects of protein tyrosine kinase inhibiton on the circulatory failure induced by endotoxin in the rat. Shock 2002; 18: 450-5.
10. Ben-Bassat H, Levitzki A, Inhibitiors of tyrosine kinases in the treatment of psoriasis. IMAJ 2000; 2: 69-73.
11. A Auricchio, G-P Gao, QC Yu, S Raper, VM Rivera, T Clackson and JM Wilson, Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer. Gene Therapy 2002; 9: 963-971.
12. Oishi, K., Ohkura, N., Kasamatsu, M., Fukushima, N., Shirai, H., Matsuda, J., Horie, S. and Ishida, N., Tissue-specific augmentation of circadian PAI-1 expression in mice with streptozotocin-induced diabetes. Thromb Res 2004; 114: 129-135.
13. Goldstein S, Shemano I, Demes R, Beilier JM, Cotten pellet granuloma method for evaluation of anti-inflammatory activity. Arch Int Pharmacodyn Ther 1976; 165: 294-301.
14. Calcutt NA, Li, L, Yaksh TL, Malmberg AB, Different effects of two aldose reductase inhibitors on noiceptin and prostaglandin E. Eur J pharmacol 1995; 285: 189-197
15. Kamei J, Saitoh A, Role of spleen or spleen products in the reduced locomotor-enhancing effect of morphine in diabetic mice. Neuroscie Lett 1996; 210: 57-60
16. Han TS, Sattar N, Williams K, Gonzalez-Villapando C, Lean MEJ, Haffner SM, Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico city diabetes study. Diabetes care 2002; 25: 2016-2021.
17. Garcia Leme J, Hamamura L, Migliorini RH and Leite M P, Influence of diabetes upon the inflammatory response of the rat. A pharmacological analysis, Eur J Pharmacol 1973; 23: 74-81.
18. Fortes ZB, Garcia-Leme J, Scivoletto R. Influence of diabetes on the reactivity of mesenteric microvessels to histamine, bradykinin and acetylcholin. Br J Pharmacol 1983; 78: 39-48.
19. Cuman RKN, Bersani-Amado CA and Fortes ZB. Influence of type 2 diabetes on the inflammatory response in rats. Inflamm Res 2001; 50: 460-465.
20. Vinegar R, Schreiber W, Hugo R, Biphasic development of carrageenan edema in rats. J Pharmacol Exp Ther 1969; 166: 96-103.
21. Vinegar R, Truax JF, Selph JH, Johnsstone PR, Venable AL, Mckenzie KK, Pathway to carrageenan-induced inflammation of the hind limb of the rat. Federation Prroceedings 1987; 6: 118-126.
22. Tomlinson A, Appleton I, Moore AR, Gilroy DW, Willis D, Mitchell JA, Willoughby DA. Cyclooxygenase and nitric oxide synthase isoforms in rat carrageenan-induced pleurisy. Br J Pharmacol 1994; 113: 693-8.
23. Tracey WR, Nakane M, Kuk J, Budzik G, Klinghofer V, Harris R, Carter G. The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleuristy in the rat. J Pharmacol Exp Ther 1995; 273: 1295-1299.
24. Salvemini D, Wang ZQ,Wyatt P, Bourdon DM, Marino MH, Manning PT, Currie MG. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 1996; 118: 829-838.
25. Cuzzocrea S., McDonald M, Mazzon E, Siriwardena D, Calabr G, Britti D, Mazullo G, De Sarro A, Caputi A P, Thiemermann C, The tyrosine kinase inhibitor tyrphostin AG 126 reduces the development of acute and chronic inflammation. Am J Pathol 2000; 157: 145-158.
26. Ismail TS, Gapalakrisan S, Begum VH, Elango V, Anti-inflammatory activity of Salacia oblonga Wall and Azima tetracantha Lam. J Ethnopharmacol 1997; 56: 145-152.
27. Swingle KF, Shideman F E, Phases of inflammatory response to subcutaneous implantation of cotton pellet and other modifications by certain anti-inflammatory agents. J Pharmacol Exp Ther 1972; 183: 226-234.
28. Fatehi-Hassanabad, Z. and Parratt, J.R. (1997). Genistein, an inhibitor of tyrosine kinase, prevents the the antiarrhythmic effects of preconditioning. Eur J Pharmacol 338:1, 67-70.
29. Mizutani K, Ikeda K, Nishikata T and Yamori 2000, Phytoestrogens attenuate oxidatie DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Hypertens 18, 1833-1840.